Event listings current as of Thursday, Oct. 25, 2024. Visit the Mobile Meeting Guide App for more details. 7 2024 INDUSTRY EVENTS The Future of AAV Gene Therapy in Congestive Heart Failure 11:15 a.m.-12 p.m. Learning Studio I SUPPORTER: Asklepios BioPharmaceutical, Inc. Overcoming the Hurdles: Address CV Risk and Weight in Appropriate Patients 11:15 a.m.-12 p.m. Learning Studio II SUPPORTER: Novo Nordisk, Inc. The Future of HTN Care Is Now: The Symplicity™ Blood Pressure Procedure 11:15 a.m.-12 p.m. Heart Theater I SUPPORTER: Medtronic Navigating Clinical Challenges: Situation Room Discussion on ATTR Cardiac Amyloidosis 11:30 a.m.-12:45 p.m. Situation Room, N427D SUPPORTER: Pfizer Inc. Evidence-Based Strategy for the Treatment of Recurrent Pericarditis 12:30-1:15 p.m. Heart Theater I SUPPORTER: Kiniksa Pharmaceuticals Corp. Exploring the Next Chapter in the Groundbreaking CRISPR Journey: Getting to the Heart of the Matter 12:30-1:15 p.m. Learning Studio I SUPPORTER: Intellia Therapeutics, Inc Finding Lp(a): “little” Things, Big Consequences 12:30-1:15 p.m. Learning Studio II SUPPORTER: Novartis Pharmaceutical Corporation Lipid Medication Adherence and Clinician Hesitation in Patients With ASCVD 12:30-1:15 p.m. Heart Theater II SUPPORTER: AHA Quality, Outcomes, Research, & Analytics (QORA) Saturday, Nov. 16
RkJQdWJsaXNoZXIy MjI2NjI=